Prognostic role of cardiovascular risk factors for men with cardiomegaly (The Reykjavik study)

American Journal of Cardiology

Volumn 78, Issue 12, 1996, Pages 1355-1361

  Sigurdsson, Emil ^b   Thorgeirsson, Gudmundur ^a   Sigvaldason, Helgi ^b   Siqfusson, Nikulas ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOMEGALY; CAUSE OF DEATH; CORONARY ARTERY DISEASE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; CARDIOMEGALY; CAUSE OF DEATH; CORONARY DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030589265     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00650-9     Document Type: Article

References (22)

1. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur Heart J 1993;14:584-591.
2. Sigurdsson E, Sigfusson N, Agnarsson U, Sigvaldason H, Thorgeirsson G. Long-term prognosis of different forms of coronary heart disease. The Reykjavik Study. Int J Epidemiol 1995;24:58-68.
3. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction, epidemiology, clinical characteristics and the prognostic role of angina pectoris. Ann Intern Med 1995;122:96-102.
4. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42-48.
5. Rose GA, Blackburn H. Cardiovascular survey methods. World Health Organ Tech Rep Ser 1968;56.
6. The World Health Organization MONICA Project. (MONItoring trends and determinants in CArdiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigator. J Clin Epidemiol 1988;41:105-114.
7. Steiner RM, Levin DC. Radiology of the heart. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: W.B. Saunders, 1992:204-234.
8. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update from the Framingham Study. N Engl J Med 1984;311:1144-1147.
9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
10. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results. JAMA 1984;251:351-374.
11. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitanaimei P, Koskinen P, Manninen V. Helsinki Heart Study: primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987;317:1237-1245.
12. Committe of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978; 40:1069-1118.
13. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-957.
14. Cheng TO. Cardiac failure in coronary heart disease. Am Heart J 1990;120:396-412.
15. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971;285:1441-1446.
16. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study - 30 years of follow-up. Hypertension 1989;13:I13-18.
17. Dzau VJ. Pathobiology of atherosclerosis and plaque complications. Am Heart J 1994;128:1300-1304.
18. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-493.
19. Chowienczyk PJ, Walts GF, Cockroft JR, Ritter JM. Impaired endothelium dependent vasodilation of forearm resistance vessels in hypercholesteraemia. Lancet 1992;340:1430-1432.
20. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
21. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992;85:1927-1938.
22. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-1596.